Press Release

Press Release

Joydeep Goswami Appointed Interim CFO; Sam Samad To Depart Illumina

Jun 9, 2022

SAN DIEGO, June 9, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced Joydeep Goswami, Chief Strategy and Corporate Development Officer, will also serve as interim Chief Financial Officer while the company conducts a search for a permanent CFO. Sam Samad will be departing Illumina on July 8, 2022, after serving as CFO for more than five years.

In addition to Goswami's current responsibilities, which include leading a variety of strategic initiatives in partnership with the Finance organization, like capital allocation, financial planning, and deal execution, he will assume all CFO duties on an interim basis. Prior to joining Illumina, Goswami had more than a decade of senior management and P&L responsibilities at Thermo Fisher Scientific, and previously served pharma, technology, and private equity clients at McKinsey & Company. He holds an M.S., Ph.D. in chemical engineering, and an MBA from the Massachusetts Institute of Technology as well as a bachelor's degree in chemical engineering from the Indian Institute of Technology, Mumbai.

"Sam has made significant contributions to our Finance organization and the company during his time at Illumina," said Francis deSouza, Illumina's Chief Executive Officer. "I'd like to thank him for his leadership and wish him every success in his future role. As we execute our CFO search, I am grateful for Joydeep's deep global business experience and collaboration with our strong Finance leadership team. He is an established, trusted leader who will bring both strategic and operational mindsets to drive shareholder value."

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit and connect with us on TwitterFacebookLinkedInInstagram, and YouTube.

Salli Schwartz

Sarah Shew
US: 858.336.3157

Cision View original content:

SOURCE Illumina, Inc.